Ingen resultater funnet.

Fortsett å skrive

    View PDF

    Myter og fakta om kosthold og IBD

    Brosjyren er for deg som har Crohns sykdom eller ulcerøs kolitt.

    REFERANSER

    • 1.

       Molodecky, NA. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30.

    • 2.

       Jahnsen, J. et al. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002 Feb;37(2):192-9.

    • 3.

       Loftus, EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004 May;126(6):1504-17.

    • 4.

       Kristensen, V. et al. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin. J Crohns Colitis. 2015 Feb;9(2):164-9

    • 5.

       Ponder, A. et al. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013 Jul 25;5:237-47

    • 6.

       Ng, SC. Et al. Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD). Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013 Apr;62(4):630-49.

    • 7.

       Wu, GD. Et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011 Oct 7;334(6052):105-8.

    • 8.

       Lewis, JD. Et al. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology. 2017 Feb;152(2):398-414.e6.

    • 9.

       Ryan, E. et al. Sarcopenia and Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis. 2019 Jan 1;25(1):67-73.

    • 10.

       Balestrieri, P. et al. Nutritional Aspects in Inflammatory Bowel Diseases. Nutrients. 2020 Jan 31;12(2):372.

    • 11.

       Levine, A. et. al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn’s disease: evaluation of the porto IBD group “growth relapse and outcomes with therapy” (GROWTH CD) study. Inflamm Bowel Dis. 2014 Feb;20(2):278-85.

    • 12.

       The Crohn’s & Colitis Foundation. Malnutrition and IBD. . [Internett]. [hentet 30 juni 2023]. Tilgjengelig fra: https://www.crohnscolitisfoundation.org/diet-and-nutrition/malnutrition-and-ibd

    • 13.

       Levine, A. et al. Effects of enteral nutrition on Crohn’s disease: clues to the impact of diet on disease pathogenesis. Inflamm Bowel Dis. 2013 May;19(6):1322-9.

    • 14.

       Levine, A. et al. Crohn’s Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial. Gastroenterology. 2019 Aug;157(2):440-450.e8.

    • 15.

       Gibson, PR. Et al. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010 Feb;25(2):252-8.

    • 16.

       Whelan, K.et al. The Low FODMAP diet in the management of irritable bowel syndrome. An evidence-based review of FODMAP restriction, reintroduction and personalization in clinical practice. J Hum Nutr. Diet, 2018; 31: 239-255

    • 17.

       Halpin, S.J. et al.. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J of Gastroenterol. 2012;107 (10): 1474-1482

    • 18.

       Limketkai, BN. Et al. Nutritional Interventions in the Patient with Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2018 Mar;47(1):155-177.

    • 19.

       Pedersen, N. et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017 May 14;23(18):3356-3366.

    • 20.

       Gibson, PR. Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:40-42.

    • 21.

       Testa, A. et al. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease. Dig Dis. 2018;36(4):271-280.

    • 22.

       Colombel, JF. Et al. AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review. Clin Gastroenterol Hepatol. 2019 Feb;17(3):380-390.e1

    • 23.

       Zhan, YL. Et al. Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review. Clin Nutr. 2018 Feb;37(1):123-129.

    • 24.

       Cox ,SR. et al. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohns Colitis. 2017 Dec 4;11(12):1420-1429.

    • 25.

       Gearry, RB. Et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis. 2009 Feb;3(1):8-14.

    • 26.

       Prince, AC. Et al. Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 May;22(5):1129-36.

    • 27.

       Maagaard, L. et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016 Apr 21;22(15):4009-19.

    • 28.

       Croagh, C. et al. Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis. 2007 Dec;13(12):1522-8.

    • 29.

       Halmos, EP. Et al. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn’s Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol. 2016 Apr 14;7(4):e164.

    • 30.

       Scaldaferri, F. et al. Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide. Gastroenterol Res Pract. 2017;2017:8646495.

    • 31.

       Gajendran, M. et al.  A comprehensive review and update on Crohn’s disease. Dis Mon. 2018 Feb;64(2):20-57.

    • 32.

       Frigstad, SO. Et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.

    • 33.

       Moum, B. et al. Seasonal variations in the onset of ulcerative colitis. Gut 1996; 38: 376-378

    • 34.

       Zeng, L. et al. Seasonal change in the exacerbations of Crohn’s disease. Scand J Gastroenterol. 1996 Jan;31(1):79-82.

    • 35.

       Mouli, VP. Et al. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014 Jan;39(2):125-36.

    • 36.

       Holick, MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81.

    • 37.

       Jørgensen, SP. et al. Crohn’s disease is associated with low vitamin D levels. J Crohns Colitis. 2013 Nov;7(10):e407-13.

    • 38.

       Frigstad, SO. et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.

    • 39.

       Raftery, T. et al. Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn’s Disease in Clinical Remission. Dig Dis Sci. 2015 Aug;60(8):2427-35.

    • 40.

       Mayur Garg, FRACP. Et al. Association of Circulating Vitamin D Concentrations with Intestinal but Not Systemic Inflammation in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, Volume 19, Issue 12, 1 November 2013, Pages 2634–2643

    • 41.

       Blanck, S. et al. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig Dis Sci. 2013 Jun;58(6):1698-702.

    • 42.

       Kabbani, TA. et al. Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol. 2016 May;111(5):712-9.

    • 43.

       Mouli, VP. et al. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014 Jan;39(2):125-36.

    • 44.

       Frigstad, SO. et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.

    • 45.

       Nordic Nutrition Recommendations.  Part 3, Vitamins A, D, E, K, Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Biotin, Panthothenic acid and vitamin C. 5th edition; 2012., s 33.

    • 46.

       Institute of Medicine (US) Committee to Review. Ross AC, Taylor CL, Yaktine AL, et al., editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. [hentet august 2023 ]. Tilgjengelig fra: https://www.ncbi.nlm.nih.gov/books/NBK56070/

    • 47.

       Bager, P. et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011 Mar;46(3):304-9.

    • 48.

       Weisshof, R. et al. Micronutrient deficiencies in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2015 Nov;18(6):576-81.

    • 49.

       Stein, J. et al. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1456-63.

    • 50.

       Stein, J. et al. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):599-610.

    • 51.

       Jelsness-Jørgensen, LP. et al. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis. 2011 Jul;17(7):1564-72.

    • 52.

       Wells, CW. et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006 Feb;12(2):123-30.

    • 53.

       Dignass, AU. et al. European Crohn’s and Colitis Organisation [ECCO]. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015 Mar;9(3):211-22.

    • 54.

       Vidal-Alaball, J. et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004655.

    • 55.

       Forbes, A. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017 Apr;36(2):321-347.

    • 56.

       Norsk legemiddelhåndbok. T4.1.2.1 Vitamin B12-mangel. [publisert 14. jun 2021; hentet 19. jun 2023]. Tilgjengelig fra: www.legemiddelhandboka.no/T4.1.2.1/Vitamin_B12-mangel

    • 57.

       Aleksandrova, K. et al. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients. 2017 Aug 30;9(9):962.

    • 58.

       Frigstad, SO. et al. Vitamin D deficiency in inflammatory bowel disease: prevalence and predictors in a Norwegian outpatient population. Scand J Gastroenterol. 2017 Jan;52(1):100-106.

    • 59.

       Helsedirektoratet. Kosthåndboken – veileder i ernæringsarbeid i helse- og omsorgstjenesten. Oslo: Helsedirektoratet; 2012 [Oppdatert: September 2016. Hentet 19. juni 2023]. Tilgjengelig fra: https://www.helsedirektoratet.no/veiledere/kosthandboken/Kosth%C3%A5ndboken%20%E2%80%93%20Veileder%20i%20ern%C3%A6ringsarbeid%20i%20helse-%20og%20omsorgstjenesten.pdf

    • 60.

       Solberg IC, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431-40

    • 61.

       Solberg IC, et al. Clinical Course in Crohn’s Disease: Results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5(12):1430-1438

    • 62.

       Helsedirektoratet. Kosthåndboken – veileder i ernæringsarbeid i helse- og omsorgstjenesten. Oslo: Helsedirektoratet; 2012 [Oppdatert: September 2016. Hentet 19. juni 2023]. s. 180-84, 187-88. Tilgjengelig fra: https://www.helsedirektoratet.no/veiledere/kosthandboken/Kosth%C3%A5ndboken%20%E2%80%93%20Veileder%20i%20ern%C3%A6ringsarbeid%20i%20helse-%20og%20omsorgstjenesten.pdf

    • 63.

       Skodje, GI. et al. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2018 Feb;154(3):529-539.e2.

    • 64.

       Skodje GI. Fruktaner gir symptomer hos personer med selvrapportert ikke-cøliakisk glutensensitivitet – ikke gluten. NGF-Nytt. 2018;1:28

    • 65.

       Gibson, PR. et al. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol. 2010 Feb;25(2):252-8.

    • 66.

       Hou, JK. et al. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011 Apr;106(4):563-73.

    • 67.

       Daley, CA. et al. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr J. 2010 Mar 10;9:10.

    • 68.

       John, S. et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010 May;22(5):602-6.

    • 69.

       Gallai, V. et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol. 1995 Feb;56(2):143-53.

    • 70.

       Bergset, T. Mat fra havet mot tarmbetennelse. [Internett]. Tidsskr Nor Legeforen, 2013.; [ hentet 30. juni 2023]. Tilgjengelig fra: https://tidsskriftet.no/2013/05/nyheter/mat-fra-havet-mot-tarmbetennelse

    • 71.

       Vasudevan, A.  et al. Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer. Cancer Prev Res (Phila). 2014 Nov;7(11):1138-48.

    • 72.

       John, S. et al. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010 May;22(5):602-6.

    • 73.

       Gallai, V. et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol. 1995 Feb;56(2):143-53.

    • 74.

       Bergset, T. Mat fra havet mot tarmbetennelse. [Internett]. Tidsskr Nor Legeforen, 2013.; [ hentet 30. juni 2023]. Tilgjengelig fra: https://tidsskriftet.no/2013/05/nyheter/mat-fra-havet-mot-tarmbetennelse

    • 75.

       Helsedirektoratet. Kostrådene. [Internett]. [oppdatert 24. okt 2016; hentet 30 juni 2023]. Tilgjengelig fra: https://www.helsedirektoratet.no/faglige-rad/kostradene-og-naeringsstoffer/kostrad-for-befolkningen

    • 76.

       Daley, CA. et al. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr J. 2010 Mar 10;9:10.

    • 77.

       Roediger, WE. et al. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology. 1993 Mar;104(3):802-9.

    • 78.

       Ijssennagger, N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):10038-43.

    • 79.

       Jowett, SL. et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004 Oct;53(10):1479-84.

    • 80.

       Albenberg, L. et al. A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares. Gastroenterology. 2019 Jul;157(1):128-136.e5.

    • 81.

       Hou, JK. et al. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011 Apr;106(4):563-73.

    • 82.

       Bernstein, CN. et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006 Jul;101(7):1559-68.)

    • 83.

       Sakamoto, N. et al. Epidemiology Group of the Research Committee on Inflammatory Bowel Disease in Japan. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005 Feb;11(2):154-63.

    • 84.

       Jantchou, P.et al. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010 Oct;105(10):2195-201.

    • 85.

       Pituch-Zdanowska, A. et al. The role of dietary fibre in inflammatory bowel disease. Prz Gastroenterol. 2015;10(3):135-41.

    • 86.

       Bowling, TE. et al. Reversal by short-chain fatty acids of colonic fluid secretion induced by enteral feeding. Lancet. 1993 Nov 20;342(8882):1266-8.

    • 87.

       Spaeth, G. et al. Secretory immunoglobulin A, intestinal mucin, and mucosal permeability in nutritionally induced bacterial translocation in rats. Ann Surg. 1994 Dec;220(6):798-808.

    • 88.

       Kleessen, B. et al. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr. 2001 Aug;86(2):291-300.

    • 89.

       Inan, MS. et al. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology. 2000 Apr;118(4):724-34.

    • 90.

       Ritchie, JK. et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn’s disease. Br Med J (Clin Res Ed). 1987 Aug 29;295(6597):517-20.

    • 91.

       Helsedirektoratet. Kosthåndboken – veileder i ernæringsarbeid i helse- og omsorgstjenesten. Oslo: Helsedirektoratet; 2012 [Oppdatert: September 2016. Hentet 19. juni 2023]. s. 185. Tilgjengelig fra: https://www.helsedirektoratet.no/veiledere/kosthandboken/Kosth%C3%A5ndboken%20%E2%80%93%20Veileder%20i%20ern%C3%A6ringsarbeid%20i%20helse-%20og%20omsorgstjenesten.pdf

    • 92.

       NAAF. Hjemmeside. [Internett]. [hentet 30 juni 2023]. Tilgjengelig fra: https://www.naaf.no/

    • 93.

       Riordan AM, et al. A review of associations between Crohn’s disease and consumption of sugars. Eur J Clin Nutr. 1998 Apr;52(4):229-38

    • 94.

       Forbes, A. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017 Apr;36(2):321-347.

    • 95.

       Chassaing, B. et al. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017 Aug;66(8):1414-1427.

    • 96.

       Mattilsynet. Hjemmeside [Internett]. [hentet 30 juni 2023]. Tilgjengelig fra: https://www.mattilsynet.no/